1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Medical Enzyme Technology Market


4. Market Overview

4.1. Definition

4.2. Market Indicators

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, 2018–2030

4.5. Global Medical Enzyme Technology Market Outlook


5. Key Insights

5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)

5.2. Technological Advancements

5.3. Major Research Institutes Involved

5.4. Disease Prevalence & Incidence Rate Globally in Key Countries

5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)


6. Global Medical Enzyme Technology Market Analysis and Forecast, by Enzyme Type

6.1. Introduction

6.2. Global Medical Enzyme Technology Market Value Share Analysis, by Enzyme Type

6.3. Global Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

6.3.1. Digestive Enzymes

6.3.1.1. L-asparginase

6.3.1.2. Lactase

6.3.1.3. Others

6.3.2. Thrombolytic Enzymes

6.3.2.1. Streptokinase

6.3.2.2. Urokinase

6.3.2.3. Others

6.3.3. Hydrolases

6.3.3.1. Hyaluronidase

6.3.3.2. Lysozyme

6.3.3.3. Others

6.3.4. Others

6.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Enzyme Type


7. Global Medical Enzyme Technology Market Analysis and Forecast, by Application

7.1. Introduction

7.2. Global Medical Enzyme Technology Market Value Share Analysis, by Application

7.3. Global Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

7.3.1. Disease Treatment

7.3.1.1. Cancer (Chemotherapy)

7.3.1.2. Metabolic Diseases

7.3.1.3. Others

7.3.2. Diagnostic Tools

7.3.2.1. Renal Disease

7.3.2.2. Cancer

7.3.2.3. Others

7.3.3. Biomedical Research

7.3.4. Others

7.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Application


8. Global Medical Enzyme Technology Market Analysis and Forecast, by Region

8.1. Regional Outlook

8.2. Introduction

8.3. Global Medical Enzyme Technology Market Value Forecast, by Region

8.3.1. North America

8.3.2. Europe

8.3.3. Asia Pacific

8.3.4. Latin America

8.3.5. Middle East & Africa

8.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Region


9. North America Medical Enzyme Technology Market Analysis and Forecast

9.1. Key Findings

9.2. North America Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

9.2.1. Digestive Enzymes

9.2.1.1. L-asparginase

9.2.1.2. Lactase

9.2.1.3. Others

9.2.2. Thrombolytic Enzymes

9.2.2.1. Streptokinase

9.2.2.2. Urokinase

9.2.2.3. Others

9.2.3. Hydrolases

9.2.3.1. Hyaluronidase

9.2.3.2. Lysozyme

9.2.3.3. Others

9.2.4. Others

9.3. North America Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

9.3.1. Disease Treatment

9.3.1.1. Cancer (Chemotherapy)

9.3.1.2. Metabolic Diseases

9.3.1.3. Others

9.3.2. Diagnostic Tools

9.3.2.1. Renal Disease

9.3.2.2. Cancer

9.3.2.3. Others

9.3.3. Biomedical Research

9.3.4. Others

9.4. North America Medical Enzyme Technology Market Value Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America Medical Enzyme Technology Market Attractiveness Analysis

9.5.1. By Enzyme Type

9.5.2. By Application

9.5.3. By Country


10. Europe Medical Enzyme Technology Market Analysis and Forecast

10.1. Key Findings

10.2. Europe Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

10.2.1. Digestive Enzymes

10.2.1.1. L-asparginase

10.2.1.2. Lactase

10.2.1.3. Others

10.2.2. Thrombolytic Enzymes

10.2.2.1. Streptokinase

10.2.2.2. Urokinase

10.2.2.3. Others

10.2.3. Hydrolases

10.2.3.1. Hyaluronidase

10.2.3.2. Lysozyme

10.2.3.3. Others

10.2.4. Others

10.3. Europe Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

10.3.1. Disease Treatment

10.3.1.1. Cancer (Chemotherapy)

10.3.1.2. Metabolic Diseases

10.3.1.3. Others

10.3.2. Diagnostic Tools

10.3.2.1. Renal Disease

10.3.2.2. Cancer

10.3.2.3. Others

10.3.3. Biomedical Research

10.3.4. Others

10.4. Europe Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Rest of Europe

10.5. Europe Medical Enzyme Technology Market Attractiveness Analysis

10.5.1. By Enzyme Type

10.5.2. By Application

10.5.3. By Country/Sub-region

11. Asia Pacific Medical Enzyme Technology Market Analysis and Forecast

11.1. Key Findings

11.2. Asia Pacific Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

11.2.1. Digestive Enzymes

11.2.1.1. L-asparginase

11.2.1.2. Lactase

11.2.1.3. Others

11.2.2. Thrombolytic Enzymes

11.2.2.1. Streptokinase

11.2.2.2. Urokinase

11.2.2.3. Others

11.2.3. Hydrolases

11.2.3.1. Hyaluronidase

11.2.3.2. Lysozyme

11.2.3.3. Others

11.2.4. Others

11.3. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

11.3.1. Disease Treatment

11.3.1.1. Cancer (Chemotherapy)

11.3.1.2. Metabolic Diseases

11.3.1.3. Others

11.3.2. Diagnostic Tools

11.3.2.1. Renal Disease

11.3.2.2. Cancer

11.3.2.3. Others

11.3.3. Biomedical Research

11.3.4. Others

11.4. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. India

11.4.3. Japan

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Medical Enzyme Technology Market Attractiveness Analysis

11.5.1. By Enzyme Type

11.5.2. By Application

11.5.3. By Country/Sub-region

12. Latin America Medical Enzyme Technology Market Analysis and Forecast

12.1. Key Findings

12.2. Latin America Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

12.2.1. Digestive Enzymes

12.2.1.1. L-asparginase

12.2.1.2. Lactase

12.2.1.3. Others

12.2.2. Thrombolytic Enzymes

12.2.2.1. Streptokinase

12.2.2.2. Urokinase

12.2.2.3. Others

12.2.3. Hydrolases

12.2.3.1. Hyaluronidase

12.2.3.2. Lysozyme

12.2.3.3. Others

12.2.4. Others

12.3. Latin America Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

12.3.1. Disease Treatment

12.3.1.1. Cancer (Chemotherapy)

12.3.1.2. Metabolic Diseases

12.3.1.3. Others

12.3.2. Diagnostic Tools

12.3.2.1. Renal Disease

12.3.2.2. Cancer

12.3.2.3. Others

12.3.3. Biomedical Research

12.3.4. Others

12.4. Latin America Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Medical Enzyme Technology Market Attractiveness Analysis

12.5.1. By Enzyme Type

12.5.2. By Application

12.5.3. By Country/Sub-region


13. Middle East & Africa Medical Enzyme Technology Market Analysis and Forecast

13.1. Key Findings

13.2. Middle East & Africa Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

13.2.1. Digestive Enzymes

13.2.1.1. L-asparginase

13.2.1.2. Lactase

13.2.1.3. Others

13.2.2. Thrombolytic Enzymes

13.2.2.1. Streptokinase

13.2.2.2. Urokinase

13.2.2.3. Others

13.2.3. Hydrolases

13.2.3.1. Hyaluronidase

13.2.3.2. Lysozyme

13.2.3.3. Others

13.2.4. Others

13.3. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

13.3.1. Disease Treatment

13.3.1.1. Cancer (Chemotherapy)

13.3.1.2. Metabolic Diseases

13.3.1.3. Others

13.3.2. Diagnostic Tools

13.3.2.1. Renal Disease

13.3.2.2. Cancer

13.3.2.3. Others

13.3.3. Biomedical Research

13.3.4. Others

13.4. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Medical Enzyme Technology Market Attractiveness Analysis

13.5.1. By Enzyme Type

13.5.2. By Application

13.5.3. By Country/Sub-region


14. Competition Landscape

14.1. Market Player - Competition Matrix (by Tier and Size of Companies)

14.2. Market Share Analysis, by Company, 2019

14.3. Company Profiles

14.3.1. Thermo Fisher Scientific Inc.

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Financial Overview

14.3.1.3. Product Portfolio

14.3.1.4. Strategic Overview

14.3.1.5. SWOT Analysis

14.3.2. Merck KGaA

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Financial Overview

14.3.2.3. Product Portfolio

14.3.2.4. Strategic Overview

14.3.2.5. SWOT Analysis

14.3.3. Genzyme Corporation (Sanofi)

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Financial Overview

14.3.3.3. Product Portfolio

14.3.3.4. Strategic Overview

14.3.3.5. SWOT Analysis

14.3.4. Promega Corporation

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Financial Overview

14.3.4.3. Product Portfolio

14.3.4.4. Strategic Overview

14.3.4.5. SWOT Analysis

14.3.5. Asahi Kasei Corporation

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Financial Overview

14.3.5.3. Product Portfolio

14.3.5.4. Strategic Overview

14.3.5.5. SWOT Analysis

14.3.6. Takeda Pharmaceutical Company Limited

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Financial Overview

14.3.6.3. Product Portfolio

14.3.6.4. Strategic Overview

14.3.6.5. SWOT Analysis

14.3.7. Cytiva (Danaher)

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Financial Overview

14.3.7.3. Product Portfolio

14.3.7.4. Strategic Overview

14.3.7.5. SWOT Analysis

14.3.8. Agilent Technologies, Inc.

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Financial Overview

14.3.8.3. Product Portfolio

14.3.8.4. Strategic Overview

14.3.8.5. SWOT Analysis

14.3.9. Sun Pharmaceutical Industries Ltd.

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Financial Overview

14.3.9.3. Product Portfolio

14.3.9.4. Strategic Overview

14.3.9.5. SWOT Analysis

14.3.10. Amano Enzyme Inc.

14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.10.2. Financial Overview

14.3.10.3. Product Portfolio

14.3.10.4. Strategic Overview

14.3.10.5. SWOT Analysis

14.3.11. Novozymes A/S

14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.11.2. Financial Overview

14.3.11.3. Product Portfolio

14.3.11.4. Strategic Overview

14.3.11.5. SWOT Analysis